These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21225291)

  • 21. A temporary decrease in twitch response following reversal of rocuronium-induced neuromuscular block with a small dose of sugammadex in a pediatric patient.
    Iwasaki H; Takahoko K; Otomo S; Sasakawa T; Kunisawa T; Iwasaki H
    J Anesth; 2014 Apr; 28(2):288-90. PubMed ID: 23963464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
    Kim JE; Chun HR
    Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.
    Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS
    Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
    Pühringer FK; Kristen P; Rex C
    Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of profound and "deep" residual rocuronium-induced neuromuscular blockade by sugammadex: a neurophysiological study.
    Pavoni V; Gianesello L; De Scisciolo G; Provvedi E; Horton D; Barbagli R; Conti P; Conti R; Giunta F
    Minerva Anestesiol; 2012 May; 78(5):542-9. PubMed ID: 22298182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency estimation of sugammadex for the reversal of moderate rocuronium-induced neuromuscular block: a non-randomized dose-response study.
    Kitajima O; Yamamoto M; Takagi S; Suzuki T
    J Anesth; 2020 Jun; 34(3):348-351. PubMed ID: 32095883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
    Mosing M; Auer U; West E; Jones RS; Hunter JM
    Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery of laryngeal nerve function with sugammadex after rocuronium-induced profound neuromuscular block.
    Pavoni V; Gianesello L; Martinelli C; Horton A; Nella A; Gori G; Simonelli M; De Scisciolo G
    J Clin Anesth; 2016 Sep; 33():14-9. PubMed ID: 27555126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of neuromuscular blockade and simultaneous increase in plasma rocuronium concentration after the intravenous infusion of the novel reversal agent Org 25969.
    Epemolu O; Bom A; Hope F; Mason R
    Anesthesiology; 2003 Sep; 99(3):632-7; discussion 6A. PubMed ID: 12960547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
    White PF; Tufanogullari B; Sacan O; Pavlin EG; Viegas OJ; Minkowitz HS; Hudson ME
    Anesth Analg; 2009 Mar; 108(3):846-51. PubMed ID: 19224792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
    Abrishami A; Ho J; Wong J; Yin L; Chung F
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007362. PubMed ID: 19821409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex.
    Staals LM; Driessen JJ; Van Egmond J; De Boer HD; Klimek M; Flockton EA; Snoeck MM
    Acta Anaesthesiol Scand; 2011 Jul; 55(6):700-7. PubMed ID: 21574968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
    Zwiers A; van den Heuvel M; Smeets J; Rutherford S
    Clin Drug Investig; 2011; 31(2):101-11. PubMed ID: 21067251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
    Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
    Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery.
    Fujita A; Ishibe N; Yoshihara T; Ohashi J; Makino H; Ikeda M; Setoguchi H
    Acta Anaesthesiol Taiwan; 2014 Jun; 52(2):54-8. PubMed ID: 25016508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.